CA2277112C
(en)
*
|
1997-01-07 |
2008-08-26 |
Amylin Pharmaceuticals, Inc. |
Use of exendins and agonists thereof for the reduction of food intake
|
US7312196B2
(en)
*
|
1997-01-08 |
2007-12-25 |
Amylin Pharmaceuticals, Inc. |
Formulations for amylin agonist peptides
|
US7910548B2
(en)
*
|
1997-06-06 |
2011-03-22 |
Amylin Pharmaceuticals, Inc. |
Methods for treating obesity
|
US6086878A
(en)
*
|
1997-08-21 |
2000-07-11 |
Dcv, Inc. |
Method of increasing muscle protein and reducing fat in animals
|
US20050272652A1
(en)
|
1999-03-29 |
2005-12-08 |
Gault Victor A |
Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
|
US7704979B2
(en)
*
|
2000-09-01 |
2010-04-27 |
The University Of Tennessee Research Foundation |
Materials and methods for the treatment or prevention of obesity
|
US6384087B1
(en)
*
|
2000-09-01 |
2002-05-07 |
University Of Tennesseee Research Corporation, Inc. |
Materials and methods for the treatment or prevention of obesity
|
US6429190B1
(en)
|
2000-12-15 |
2002-08-06 |
Pacifichealth Laboratories, Inc. |
Method for extending the satiety of food by adding a nutritional composition designed to stimulate cholecystokinin(CCK)
|
US20030165574A1
(en)
*
|
2002-03-01 |
2003-09-04 |
Ward Loren Spencer |
Compositions and methods for treatment of body weight conditions
|
US7790670B2
(en)
*
|
2002-03-01 |
2010-09-07 |
Glanbia Nutritionals (Ireland) Ltd. |
Compositions and methods for treatment of body weight conditions
|
US7105526B2
(en)
|
2002-06-28 |
2006-09-12 |
Banyu Pharmaceuticals Co., Ltd. |
Benzimidazole derivatives
|
ATE468114T1
(de)
*
|
2002-11-08 |
2010-06-15 |
High Point Pharmaceuticals Llc |
Sichere chemische entkuppler zur behandlung von fettsucht
|
EP1424070A1
(en)
*
|
2002-11-28 |
2004-06-02 |
Fournier Laboratories Ireland Limited |
Combination of a PPAR alpha agonist and metformin for decreasing the serum triglycerides
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
US20070275877A1
(en)
*
|
2003-08-29 |
2007-11-29 |
Amylin Pharmaceuticals, Inc. |
Methods for Treating or Ameliorating Ghrelin-Associated Diseases and Disorders
|
CN1902177A
(zh)
|
2003-09-22 |
2007-01-24 |
万有制药株式会社 |
新哌啶衍生物
|
EP1789440A4
(en)
*
|
2004-02-11 |
2008-03-12 |
Amylin Pharmaceuticals Inc |
REASONS FOR THE FAMILY OF PANCREATIC POLYPEPTIDES AND POLYPEPTIDES CONTAINING THEM
|
JP2007525495A
(ja)
*
|
2004-02-11 |
2007-09-06 |
アミリン・ファーマシューティカルズ,インコーポレイテッド |
選択可能な特性を有するハイブリッドポリペプチド
|
WO2006083254A1
(en)
|
2004-02-11 |
2006-08-10 |
Amylin Pharmaceuticals, Inc. |
Amylin family peptides and methods for making and using them
|
US8076288B2
(en)
|
2004-02-11 |
2011-12-13 |
Amylin Pharmaceuticals, Inc. |
Hybrid polypeptides having glucose lowering activity
|
US7399744B2
(en)
*
|
2004-03-04 |
2008-07-15 |
Amylin Pharmaceuticals, Inc. |
Methods for affecting body composition
|
NZ550944A
(en)
*
|
2004-04-02 |
2009-12-24 |
Univ Tennessee Res Foundation |
Dairy components effective for fat loss
|
AU2005272627A1
(en)
*
|
2004-08-13 |
2006-02-23 |
Amgen Inc. |
Substituted benzofused heterocycles
|
US20080254108A1
(en)
*
|
2004-08-23 |
2008-10-16 |
Mark Rosenberg |
Formulations and Methods for Modulating Satiety
|
JP2006117650A
(ja)
*
|
2004-09-27 |
2006-05-11 |
Kao Corp |
除草剤組成物
|
US8394765B2
(en)
*
|
2004-11-01 |
2013-03-12 |
Amylin Pharmaceuticals Llc |
Methods of treating obesity with two different anti-obesity agents
|
EP2286837A3
(en)
|
2004-11-01 |
2013-09-04 |
Amylin Pharmaceuticals, LLC |
Treatment of obesity and obesity related diseases
|
US8263545B2
(en)
|
2005-02-11 |
2012-09-11 |
Amylin Pharmaceuticals, Inc. |
GIP analog and hybrid polypeptides with selectable properties
|
JP2008530130A
(ja)
*
|
2005-02-11 |
2008-08-07 |
アミリン・ファーマシューティカルズ,インコーポレイテッド |
Gip類似体および選択可能な特性を備えるハイブリッドポリペプチド
|
WO2006105527A2
(en)
*
|
2005-03-31 |
2006-10-05 |
Amylin Pharmaceuticals, Inc. |
Amylin and amylin agonists for treating psychiatric diseases and disorders
|
CN101193647A
(zh)
*
|
2005-04-11 |
2008-06-04 |
田纳西大学研究基金会 |
有效减少脂肪的稳定的奶制品成分
|
US8138206B2
(en)
|
2005-05-30 |
2012-03-20 |
Msd. K.K. |
Piperidine derivative
|
CA2618112A1
(en)
|
2005-08-10 |
2007-02-15 |
Banyu Pharmaceutical Co., Ltd. |
Pyridone compound
|
CA2617649A1
(en)
*
|
2005-08-11 |
2007-02-22 |
Amylin Pharmaceuticals, Inc. |
Hybrid polypeptides with selectable properties
|
BRPI0614649A2
(pt)
|
2005-08-11 |
2011-04-12 |
Amylin Pharmaceuticals Inc |
polipeptìdeos hìbridos com propriedades selecionáveis
|
EA014647B1
(ru)
*
|
2005-08-11 |
2010-12-30 |
Амилин Фармасьютикалз, Инк. |
Гибридные полипептиды с селектируемыми свойствами
|
WO2007024004A1
(ja)
|
2005-08-24 |
2007-03-01 |
Banyu Pharmaceutical Co., Ltd. |
フェニルピリドン誘導体
|
US20090264426A1
(en)
|
2005-09-07 |
2009-10-22 |
Shunji Sakuraba |
Bicyclic aromatic substituted pyridone derivative
|
CA2624030A1
(en)
|
2005-09-29 |
2007-04-12 |
Tianying Jian |
Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
|
AU2006304836A1
(en)
|
2005-10-21 |
2007-04-26 |
Novartis Ag |
Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent
|
US8168592B2
(en)
*
|
2005-10-21 |
2012-05-01 |
Amgen Inc. |
CGRP peptide antagonists and conjugates
|
AU2006307046A1
(en)
|
2005-10-27 |
2007-05-03 |
Msd K.K. |
Novel benzoxathiin derivative
|
ES2381205T3
(es)
|
2005-11-10 |
2012-05-24 |
Msd K.K. |
Derivado espiro aza-sustituido
|
US8497240B2
(en)
|
2006-08-17 |
2013-07-30 |
Amylin Pharmaceuticals, Llc |
DPP-IV resistant GIP hybrid polypeptides with selectable properties
|
EP2698157B1
(en)
|
2006-09-22 |
2015-05-20 |
Merck Sharp & Dohme Corp. |
Method of treatment using fatty acid synthesis inhibitors
|
EP2072519A4
(en)
|
2006-09-28 |
2009-10-21 |
Banyu Pharma Co Ltd |
DIARYLKETIMINDERIVAT
|
JP5319518B2
(ja)
|
2007-04-02 |
2013-10-16 |
Msd株式会社 |
インドールジオン誘導体
|
US20100120694A1
(en)
|
2008-06-04 |
2010-05-13 |
Synergy Pharmaceuticals, Inc. |
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
EP2527360B1
(en)
|
2007-06-04 |
2015-10-28 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
CN101939022A
(zh)
*
|
2007-11-14 |
2011-01-05 |
安米林药品公司 |
治疗肥胖以及肥胖相关疾病和病症的方法
|
AU2009220605A1
(en)
|
2008-03-06 |
2009-09-11 |
Msd K.K. |
Alkylaminopyridine derivative
|
JPWO2009119726A1
(ja)
|
2008-03-28 |
2011-07-28 |
Msd株式会社 |
メラニン凝集ホルモン受容体拮抗作用を有するジアリールメチルアミド誘導体
|
AU2009261248A1
(en)
|
2008-06-19 |
2009-12-23 |
Banyu Pharmaceutical Co., Ltd. |
Spirodiamine-diarylketoxime derivative
|
ES2624828T3
(es)
|
2008-07-16 |
2017-07-17 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
|
WO2010013595A1
(ja)
|
2008-07-30 |
2010-02-04 |
萬有製薬株式会社 |
5員-5員又は5員-6員縮環シクロアルキルアミン誘導体
|
AU2009307884B2
(en)
|
2008-10-22 |
2014-07-31 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
WO2010051236A1
(en)
|
2008-10-30 |
2010-05-06 |
Merck Sharp & Dohme Corp. |
Isonicotinamide orexin receptor antagonists
|
CN102271509A
(zh)
|
2008-10-31 |
2011-12-07 |
默沙东公司 |
用于抗糖尿病药的新型环苯并咪唑衍生物
|
AU2010206614B2
(en)
*
|
2009-01-22 |
2015-03-26 |
Keybioscience Ag |
Treatment for obesity
|
US20120071401A1
(en)
*
|
2009-04-10 |
2012-03-22 |
Amylin Pharamaceuticals, Inc. |
Amylin agonist compounds for estrogen-deficient mammals
|
WO2011106273A1
(en)
|
2010-02-25 |
2011-09-01 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
US9782454B2
(en)
|
2010-04-22 |
2017-10-10 |
Longevity Biotech, Inc. |
Highly active polypeptides and methods of making and using the same
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
BR112013021236B1
(pt)
|
2011-02-25 |
2021-05-25 |
Merck Sharp & Dohme Corp |
composto derivado de benzimidazol, e, composição
|
AR088352A1
(es)
|
2011-10-19 |
2014-05-28 |
Merck Sharp & Dohme |
Antagonistas del receptor de 2-piridiloxi-4-nitrilo orexina
|
US9533022B2
(en)
|
2011-11-02 |
2017-01-03 |
KeyBioscience A/S |
Peptide analogs for treating diseases and disorders
|
US9006172B2
(en)
|
2011-11-02 |
2015-04-14 |
Keybioscience Ag |
Peptide analogs for treating diseases and disorders
|
US8575091B1
(en)
|
2012-04-19 |
2013-11-05 |
Novo Nordisk A/S |
Amylin analogues and pharmaceutical compositions thereof
|
ES2640285T3
(es)
*
|
2012-04-19 |
2017-11-02 |
Novo Nordisk A/S |
Análogos de amilina humana
|
WO2014022528A1
(en)
|
2012-08-02 |
2014-02-06 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
AU2014219020A1
(en)
|
2013-02-22 |
2015-07-23 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
US9650375B2
(en)
|
2013-03-14 |
2017-05-16 |
Merck Sharp & Dohme Corp. |
Indole derivatives useful as anti-diabetic agents
|
EP2968469A4
(en)
|
2013-03-15 |
2016-08-31 |
Longevity Biotech Inc |
PEPTIDES COMPRISING NON-ENDOGENIC AMINO ACIDS AND METHODS OF MAKING AND USING SAME
|
WO2014151200A2
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|
WO2014151206A1
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
US10011637B2
(en)
|
2013-06-05 |
2018-07-03 |
Synergy Pharmaceuticals, Inc. |
Ultra-pure agonists of guanylate cyclase C, method of making and using same
|
CN103416598B
(zh)
*
|
2013-07-04 |
2014-07-02 |
新疆农业大学 |
一种微囊包被卵黄源胆囊收缩素抗体的制备方法
|
WO2015051496A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
AU2015308350B2
(en)
|
2014-08-29 |
2020-03-05 |
Tes Pharma S.R.L. |
Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
|
CN109952292A
(zh)
|
2016-10-14 |
2019-06-28 |
Tes制药有限责任公司 |
α-氨基-β-羧基己二烯二酸半醛去羧酶的抑制剂
|
US11072602B2
(en)
|
2016-12-06 |
2021-07-27 |
Merck Sharp & Dohme Corp. |
Antidiabetic heterocyclic compounds
|
WO2018118670A1
(en)
|
2016-12-20 |
2018-06-28 |
Merck Sharp & Dohme Corp. |
Antidiabetic spirochroman compounds
|
JP2022504596A
(ja)
*
|
2018-10-11 |
2022-01-13 |
インターシア セラピューティクス,インコーポレイティド |
ヒトアミリンアナログペプチド及び使用方法
|
AR117122A1
(es)
|
2018-11-20 |
2021-07-14 |
Tes Pharma S R L |
INHIBIDORES DE LA ÁCIDO a-AMINO-b-CARBOXIMUCÓNICO SEMIALDEHÍDO DESCARBOXILASA
|
WO2020167706A1
(en)
|
2019-02-13 |
2020-08-20 |
Merck Sharp & Dohme Corp. |
5-alkyl pyrrolidine orexin receptor agonists
|
WO2021026047A1
(en)
|
2019-08-08 |
2021-02-11 |
Merck Sharp & Dohme Corp. |
Heteroaryl pyrrolidine and piperidine orexin receptor agonists
|
CN116249697A
(zh)
|
2020-08-18 |
2023-06-09 |
默沙东有限责任公司 |
二环庚烷吡咯烷食欲素受体激动剂
|
CN113929737A
(zh)
*
|
2021-10-20 |
2022-01-14 |
中国科学院香港创新研究院再生医学与健康创新中心有限公司 |
一种多肽及其作为cck受体激动剂/拮抗剂的应用
|